Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
2014 · BMC Urology · 71 citations
https://doi.org/10.1186/1471-2490-14-33
E
Eijiro Okajima
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
97
Papers
1.2K
Citations
19
h-index
34
i10-index
Eijiro Okajima is an academic researcher from Nara City Hospital. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Prostate Cancer Treatment and Research. The author has an h-index of 19, co-authored 83 publications.
Papers by this author
worksInfrequent somatic alteration of p16/MTS1 in human primary superficial bladder cancers
1996 · Cancer Letters · 19 citations
https://doi.org/10.1016/0304-3835(96)04225-5
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
2020 · Journal of bone oncology · 13 citations
https://doi.org/10.1016/j.jbo.2020.100344
Cripto expression in human urological tumors
1997 · Cancer Letters · 6 citations
https://doi.org/10.1016/s0304-3835(96)04559-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat